An international research team found some beneficial bacteria in people’s guts may not return after broad-spectrum antibiotic exposure, according to a study published in Nature Microbiology. 1.

Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic therapy ...

In a study published in the Journal of Oral Microbiology, ADA Forsyth scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates ...

Individual risk assessment with automated EHR alerts are an effective and safe strategy to limit use of extended-spectrum antibiotics in patients hospitalized with UTI. An antibiotic stewardship ...

Changes in gut microbiome diversity are observed with certain antibiotic drugs years later, even after just one course of ...

Among adults treated for community-acquired pneumonia in the outpatient setting, broad-spectrum antibiotics vs macrolide monotherapy were associated with an increased risk for adverse drug events.

Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and ...

Human clinical trials demonstrate that functionally targeted Omni-Biotic AB 10 prevents diarrhea, reduces C. difficile risk, ...

Researchers at McMaster University have identified manikomycin, a novel antibiotic candidate that attacks a previously ...